- $1.99bn
- $3.51bn
- $1.46bn
- 32
- 65
- 57
- 50
C2019 December 31st | C2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 908 | 576 | 1,245 | 1,652 | 1,458 |
Cost of Revenue | |||||
Gross Profit | 663 | 328 | 958 | 1,340 | 1,066 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 695 | 997 | 870 | 916 | 1,248 |
Operating Profit | 213 | -421 | 375 | 736 | 210 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 22.6 | -430 | -185 | 384 | 127 |
Provision for Income Taxes | |||||
Net Income After Taxes | 58.7 | -466 | -183 | 382 | 187 |
Net Income Before Extraordinary Items | |||||
Net Income | 58.7 | -466 | -183 | 382 | 187 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 58.7 | -466 | -183 | 382 | 187 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 1.32 | -4.17 | -1.73 | 4.99 | 1.73 |